Cellectis (CLLS) Total Current Liabilities (2013 - 2026)

Cellectis' Total Current Liabilities history runs 14 years deep, the most recent figure standing at $134.5 million for Q1 2026.

• On a quarterly basis, Total Current Liabilities fell 17.27% year-over-year to $134.5 million in Q1 2026; TTM through Mar 2026 was $134.5 million, a 17.27% decrease from a year earlier, with the FY2025 full-year figure at $145.8 million, down 12.34% from the prior year.
• Total Current Liabilities slipped to $134.5 million in Q1 2026 per CLLS's latest filing, from $145.8 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $167.4 million in Q2 2025 and bottomed at $42.0 million in Q2 2023.
• The 5-year median for Total Current Liabilities is $145.8 million (2025), against an average of $111.9 million.
• Across the five-year window, Total Current Liabilities fell 23.94% in 2023 and soared 279.65% in 2024, its largest moves.
• Year by year, Total Current Liabilities stood at $48.1 million in 2022, then soared by 222.34% to $155.1 million in 2023, then gained by 7.17% to $166.3 million in 2024, then decreased by 12.34% to $145.8 million in 2025, then slipped by 7.72% to $134.5 million in 2026.
• Per Business Quant, the three latest CLLS Total Current Liabilities figures stand at $134.5 million (Q1 2026), $145.8 million (Q4 2025), and $148.6 million (Q3 2025).